Parallel Advisors, LLC Invitae Corp Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$0.01 - $0.61 $10 - $610	-1,000 Reduced 19.35%	4,168 $0
Q4 2023 Feb 09, 2024	BUY	$0.42 - $0.72 $20 - $35	49 Added 0.96%	5,168 $3,000
Q3 2023 May 20, 2024	SELL	$0.6 - $1.53 $180 - $459	-300 Reduced 5.54%	5,119 $3,000
Q3 2023 Nov 13, 2023	SELL	$0.6 - $1.53 $180 - $459	-300 Reduced 5.54%	5,119 $3,000
Q1 2023 May 20, 2024	BUY	$1.2 - $2.73 $1,501 - $3,415	1,251 Added 30.01%	5,419 $7,000
Q1 2023 Apr 25, 2023	SELL	$1.2 - $2.73 $3,211 - $7,305	-2,676 Reduced 33.06%	5,419 $7,000
Q4 2022 Feb 03, 2023	BUY	$1.71 - $3.61 $4,652 - $9,822	2,721 Added 50.63%	8,095 $15,000
Q3 2022 Nov 10, 2022	SELL	$1.9 - $8.63 $469 - $2,131	-247 Reduced 4.39%	5,374 $13,000
Q2 2022 Aug 01, 2022	BUY	$2.13 - $9.01 $449 - $1,901	211 Added 3.9%	5,621 $14,000
Q1 2022 Apr 28, 2022	SELL	$6.28 - $15.59 $1,588 - $3,944	-253 Reduced 4.47%	5,410 $45,000
Q4 2021 Jan 20, 2022	BUY	$14.7 - $28.67 $66,664 - $130,018	4,535 Added 402.04%	5,663 $86,000
Q3 2021 Nov 02, 2021	BUY	$24.31 - $33.6 $10,356 - $14,313	426 Added 60.68%	1,128 $32,000
Q2 2021 Aug 06, 2021	SELL	$26.09 - $40.4 $2,008 - $3,110	-77 Reduced 9.88%	702 $24,000
Q3 2020 Oct 27, 2020	SELL	$28.43 - $44.67 $19,901 - $31,269	-700 Reduced 47.33%	779 $34,000
Q2 2020 Jul 16, 2020	BUY	$11.71 - $30.29 $16,757 - $43,344	1,431 Added 2981.25%	1,479 $44,000
Q1 2020 Apr 27, 2020	SELL	$7.64 - $27.5 $7,754 - $27,912	-1,015 Reduced 95.48%	48 $0
Q2 2019 Aug 05, 2019	BUY	$17.37 - $26.27 $18,464 - $27,925	1,063 New	1,063 $25,000
Q1 2019 May 01, 2019	SELL	$10.65 - $25.75 $1,065 - $2,575	-100 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$7.86 - $9.99 $786 - $999	100	100 $1,000

Others Institutions Holding NVTA

# of Institutions

Shares Held

1.92M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account